Skip to main content
Malin Corporation Plc logo

Malin Corporation Plc — Investor Relations & Filings

Ticker · MLC ISIN · IE00BVGC3741 LEI · 635400JG4YSDU5U1YU17 IR Financial and insurance activities
Open in API
Filings indexed 180 across all filing types
Latest filing 2021-11-04 Regulatory Filings
Country IE Ireland
Listing IR MLC

About Malin Corporation Plc

http://malinplc.com/

Malin Corporation Plc is an investment company that provides long-term capital and operational expertise to highly innovative life sciences companies. The company focuses on private businesses operating in the therapeutics, medical devices, and diagnostics sectors. Its investment strategy is concentrated on specific therapeutic areas, primarily oncology, immunology, and genetic diseases. Malin supports its portfolio companies across various stages of development, from initial science and discovery through to clinical and commercial phases, with the objective of fostering the development of transformative technologies and outcomes for patients.

Recent filings

Filing Released Lang Actions
Block listing Interim Review
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' and contains a 'Schedule 6 - BLOCK LISTING SIX MONTHLY RETURN'. This type of filing reports on the status of unallotted securities under an incentive plan over a six-month period (May 4, 2021, to November 3, 2021). This is a specific regulatory disclosure related to share capital/incentive plans, but it does not fit neatly into the defined categories like 'SHA' (Share Issue/Capital Change) which usually implies a transaction or change in structure, or 'POS' (Transaction in Own Shares). Since it is a formal, periodic regulatory filing that doesn't match a more specific category, the most appropriate fallback is 'RNS' (Regulatory Filings), which serves as the general category for miscellaneous regulatory announcements.
2021-11-04 English
Update on Litigation by Founder Shareholders
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a date (13 October 2021) and a brief update regarding litigation initiated by founder shareholders and the company's intent to return capital. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement disseminated via the RNS system. Since the content is a specific legal/litigation update that doesn't fit perfectly into ER, 10-K, or DIRS, and it is a short announcement rather than a full report, the most appropriate classification is the general regulatory filing category, RNS, as per the definition: 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories.' The document length is short (3679 chars), supporting the idea that it is an announcement, not a comprehensive report.
2021-10-13 English
Malin Rejects A Ordinary Share Conversion Notices
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and is distributed via 'RNS, the news service of the London Stock Exchange'. It contains an announcement dated October 8, 2021, regarding a corporate dispute over A Ordinary Share conversion notices and potential litigation. This is a general, time-sensitive corporate announcement disseminated through an official regulatory news service, but it does not fit the specific definitions for Earnings Release (ER), Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or a specific financial report (10-K, IR). Since it is a regulatory announcement distributed via RNS that doesn't fit a more specific category like DIV, CAP, or MANG, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is substantial enough (8497 chars) that it is not merely an announcement *of* a report (RPA), but the report itself.
2021-10-08 English
Sale of Altan and Capital Returns Update
Capital/Financing Update Classification · 99% confidence The document is a formal announcement disseminated via RNS (RNS Number: 6318N) on October 1, 2021. It details the completion of a major corporate transaction (sale of Altan Pharma) and outlines the subsequent plan for a significant return of capital to shareholders via a tender offer, which will require shareholder approval at a general meeting. This type of announcement, which communicates material corporate actions and financial updates outside of standard periodic reports (like 10-K or IR), is typically classified as a general regulatory announcement. Since it is not a specific report (like ER, IR, or 10-K) but rather a material update distributed through the regulatory news service, the most appropriate classification is Regulatory Filings (RNS). The document length is short (3913 chars) and it functions as a news release, not the detailed financial report itself.
2021-10-01 English
Share Buyback
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Share Buyback' where the company purchased its own ordinary shares for cancellation. This action directly corresponds to the definition of 'Transaction in Own Shares'. The document is short and appears to be a direct regulatory announcement, not a comprehensive report. The presence of 'RNS Number' and the closing statement referencing RNS confirms it is a regulatory filing, but the specific content points directly to the POS code. The key phrase is 'Malin Corporation plc announces that on 30 August 2021 it purchased 762,281 ordinary shares... for cancellation.'
2021-08-31 English
Interim Results 2021
Earnings Release Classification · 100% confidence The document explicitly states, 'Malin Corporation plc... today publishes its interim results and interim report for the six month period to 30 June 2021.' This clearly identifies the content as a comprehensive financial report covering a period shorter than a year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). Although it mentions a conference call (CT) and provides RNS information, the primary purpose and content are the interim financial results. H1 2021
2021-08-26 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.